• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
79,273.33 753.03
( 0.96%)
Global Indices
Nasdaq
49,464.98 -3.46
(-0.01%)
Dow Jones
7,130.75 -16.31
(-0.23%)
Hang Seng
59,361.39 536.50
(0.91%)
Nikkei 225
10,604.22 -63.41
(-0.59%)
Forex
USD-INR
92.58 -0.61
(-0.65%)
EUR-INR
108.87 -0.98
(-0.89%)
GBP-INR
125.07 -1.17
(-0.93%)
JPY-INR
0.58 0.00
(-0.45%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
62.7662681
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
14.42
124.93
EPS(TTM)
Face Value()
Div & Yield %
5.44
10
1.53
 

yaari digital integrated services ltd
Wipro to acquire Olam Group's IT service arm 'Mindsprint'
Apr 06,2026
Wipro (through its subsidiaries) has signed a definitive agreement to acquire 100% shareholding in Mindsprint and its subsidiaries on 05 April 2026. The transaction is expected to close by 30 June 2026 and involves a purchase consideration of USD 375 million.

The agreement forms part of Wipro's engagement with Olam Group, a leading USD 50+ Billion Food and Agri-business headquartered in Singapore. Mindsprint is Olam Group's IT services arm. Headquartered in Singapore and founded in 2007, Mindsprint provides technology and digital transformation services across enterprise applications, data & analytics, digital platform engineering, customer experience, cloud & infrastructure, cybersecurity, and business process services. Mindsprint has a global workforce of 3,200+ employees across India, Singapore, US, UK and Middle East.

Mindsprint has strong Food and Agri-business domain experience, supply chain transformation capabilities, and proprietary IP-driven solutions.